Balance sheet - the Novozymes Group


Audited by PwC
Note Dec. 31, 2009   Dec. 31, 2008
      DKK million DKK million  
ASSETS
10 Intangible assets 1,124  1,179 
11 Property, plant and equipment 4,804  4,319 
12 Deferred tax assets 62  68 
13 Other financial assets   75   
Total non-current assets 5,991  5,641 
14 Inventories 1,535  1,557 
15 Trade receivables 1,468  1,450 
16 Tax receivables 210  18 
17 Other receivables 215  146 
13 Other financial assets 187  116 
Cash at bank and in hand   1,284  997   
Total current assets 4,899  4,284 
Total assets   10,890  9,925   
           
LIABILITIES AND SHAREHOLDERS' EQUITY
18 Common stock 650  650 
18 Treasury stock (1,624) (1,791)
Other reserves 154  (32)
Retained earnings 6,651  5,638 
19 Minority interests   10  11   
Total shareholders' equity 5,841  4,476 
12 Deferred tax liabilities 694  850 
20 Long-term employee benefits 13  16 
21 Provisions 125  121 
22 Other financial liabilities   1,696  1,576   
Total non-current liabilities 2,528  2,563 
22 Other financial liabilities 632  1,092 
21 Provisions 30  33 
Trade payables 531  630 
16 Tax payables 97  161 
23 Other payables   1,231  970   
Total current liabilities 2,521  2,886 
         
Total liabilities 5,049  5,449 
Total liabilities and shareholders' equity 10,890  9,925   
My Report